Search Result "VELCADE"
Allosteric Regulators of the Proteasome: Potential Drugs and a Novel Approach for Drug Design
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2006 Page: 155-165
Author(s): Xiaolin Tan, Pawel A. Osmulski, Maria Gaczynska
The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1483-1499
Author(s): Boris Cvek, Zdenek Dvorak
The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7 Issue: 4 Year: 2007 Page: 250-273
Author(s): Imtiaz M. Shah, Mario Di Napoli
The Current Status and Perspectives of Delivery Strategy for Boronbased Drugs
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 26 Year: 2019 Page: 5019-5035
Author(s): Zhu Yinghuai,Xinglong Lin,Hongming Xie,Jianlin Li,Narayan S. Hosmane,Yingjun Zhang
Inhibitors of the Ubiquitin-Proteasome System and the Cell Death Machinery: How Many Pathways are Activated?
Journal: Current Molecular Pharmacology
Volume: 1 Issue: 1 Year: 2008 Page: 24-37
Author(s): Claudio Brancolini
Bortezomib as an Antitumor Agent
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 6 Year: 2006 Page: 441-448
Author(s): A. M. Roccaro, T. Hideshima, P. G. Richardson, D. Russo, D. Ribatti, A. Vacca, F. Dammacco, K. C. Anderson
Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 7 Year: 2005 Page: 529-541
Author(s): Kenyon G. Daniel, Deborah J. Kuhn, Aslamuzzaman Kazi, Q. P. Dou
Deubiquitinating Enzymes as Therapeutic Targets in Cancer
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4039-4052
Author(s): Key-Hwan Lim, Kwang-Hyun Baek
The Immunoproteasome as a Therapeutic Target for Hematological Malignancies
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 6 Year: 2014 Page: 537-548
Author(s): Zachary Miller,Wooin Lee,Kyung Bo Kim
Recent Advances in the Treatment of Multiple Myeloma
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 381-393
Author(s): Hiroshi Yasui, Teru Hideshima, Paul G. Richardson, Kenneth C. Anderson